By Dr. Sasi Kiran Attili, Consultant Dermatologist & Dermatopathologist

Minoxidil is widely used for female-pattern hair loss, but its use around pregnancy raises important questions. Topical minoxidil is not recommended during pregnancy because its safety has not been established, although it has not been proven to cause birth defects in humans. Women using topical minoxidil do not automatically need contraception solely because of this treatment. However, stopping when pregnancy is planned or recognised is advisable. Oral minoxidil requires greater caution.

Is Topical Minoxidil Safe When Planning Pregnancy?

Women using topical minoxidil for hair loss are generally advised to discontinue treatment when planning pregnancy.

This recommendation does not mean that minoxidil has been conclusively shown to harm the developing baby. Rather, there is insufficient reliable human pregnancy data to establish its safety.

The British Association of Dermatologists advises avoiding minoxidil when planning pregnancy. UK prescribing information also advises against topical minoxidil during pregnancy.

However, topical minoxidil product information does not specifically require women of childbearing age to use contraception.

There is an important distinction between advising against taking a medicine during pregnancy and requiring contraception throughout treatment.

A woman who wants to become pregnant can therefore discuss discontinuing topical minoxidil with her dermatologist rather than assuming that she must avoid conception indefinitely.

What If I Used Minoxidil Before Knowing I Was Pregnant?

Accidental exposure during early pregnancy does not mean that fetal damage has occurred.

A small number of case reports have described fetal abnormalities following maternal minoxidil exposure. One published report involved a woman using topical 2% minoxidil during pregnancy. However, an individual case report cannot establish that the medication caused the abnormalities.

A prospective observational study of topical minoxidil users reported no apparent increase in adverse pregnancy outcomes, although the study was not designed to establish safety during pregnancy or reliably exclude uncommon fetal abnormalities.

The available evidence cannot establish either that topical minoxidil is completely safe or that an individual exposure has caused harm.

If pregnancy is recognised while using minoxidil, discontinue the topical treatment and inform your obstetrician or prescribing dermatologist. The timing, formulation, frequency and duration of exposure can then be reviewed.

Previous exposure alone is not evidence of fetal harm and should not automatically be interpreted as a reason for pregnancy termination or additional invasive investigations.

How Much Topical Minoxidil Enters the Bloodstream?

When applied to healthy, intact scalp skin, approximately 1–2% of a topical minoxidil solution is absorbed systemically.

This is substantially lower than the systemic exposure associated with oral treatment. Absorption can nevertheless vary with the formulation, the condition of the scalp and the way the product is used.

Animal studies have shown reproductive toxicity, generally at exposures much greater than those expected from ordinary topical application.

These findings help explain why topical minoxidil is considered lower exposure than oral minoxidil. They do not, however, prove that topical treatment is safe during pregnancy.

Because female-pattern hair loss is generally not an urgent medical condition, avoiding unnecessary fetal exposure is usually the reasonable choice.

Can I Use Topical Minoxidil While Breastfeeding?

Recommendations differ.

UK topical minoxidil product information advises against use during breastfeeding. However, the US National Library of Medicine’s LactMed database considers maternal topical minoxidil acceptable once breastfeeding is established, while acknowledging that the supporting evidence is limited.

There have been reports of excessive hair growth in infants exposed to minoxidil, including through suspected direct contact with treated skin.

If topical minoxidil is considered during established breastfeeding, precautions include:

• Applying it only to the scalp, never to the breasts.
• Washing hands thoroughly after application.
• Allowing the application site to dry and preventing the infant from contacting treated scalp or hair.
• Preventing accidental transfer through close skin-to-skin contact.
• Seeking medical advice before use when breastfeeding a premature infant or newborn.

These precautions reduce avoidable exposure but do not establish absolute safety.

Is Oral Minoxidil Different?

Yes. Oral minoxidil produces considerably greater systemic exposure than topical treatment.

Low-dose oral minoxidil is sometimes prescribed off-label for hair loss. However, UK oral minoxidil prescribing information advises against its use during pregnancy and in women of childbearing potential who are not using contraception.

Women receiving oral minoxidil for hair loss should therefore receive appropriate contraception and pregnancy-planning advice.

Oral minoxidil is also detectable in breast milk. Although LactMed does not describe it as absolutely contraindicated during breastfeeding, it recommends caution because information is limited.

For elective hair-loss treatment, avoiding oral minoxidil during pregnancy and generally during breastfeeding is the more cautious approach.

Does Postpartum Hair Loss Always Need Minoxidil?

No. Increased hair shedding after delivery is common, often beginning a few months postpartum.

This usually represents postpartum telogen effluvium, a temporary shift in the hair-growth cycle. Many women recover without specific hair-growth medication.

However, prolonged shedding, progressive thinning, patchy hair loss, scalp inflammation or other unusual symptoms may indicate a different or additional condition.

Distinguishing temporary postpartum shedding from underlying female-pattern hair loss is important before deciding whether medication is appropriate.

Frequently Asked Questions

Does topical minoxidil affect my ability to become pregnant?

There is no convincing human evidence that ordinary topical minoxidil treatment reduces fertility, but specific reproductive safety data are limited. Pregnancy avoidance and fertility impairment are separate questions.

Do I need to wait several months after stopping topical minoxidil before trying to conceive?

There is no established, evidence-based mandatory washout interval specified in the cited UK topical product information. Discuss the timing of discontinuation with your dermatologist when planning pregnancy.

Will stopping minoxidil cause more hair loss?

The hair-growth benefits of minoxidil are generally lost after treatment is discontinued. This is a treatment-maintenance issue rather than evidence of harm from stopping the medicine.

When Should You Seek Dermatological Advice?

If you are planning pregnancy, breastfeeding, or experiencing persistent hair loss after delivery, the first question is whether the hair loss requires treatment at all.

Female-pattern hair loss, telogen effluvium, alopecia areata and inflammatory scalp disorders can require different approaches. Examination and selected investigations may be necessary if the diagnosis is uncertain.

At Online Skin Specialist, Dr. Sasi Kiran Attili provides dermatologist-reviewed educational assessments of skin and hair concerns. These reviews can help you understand possible diagnoses and questions to discuss with your treating clinician. They do not replace obstetric care, a medical consultation or a prescription.

References

1. Smorlesi C, et al. Topically applied minoxidil may cause fetal malformation: a case report. Birth Defects Research, 2003.
2. Shapiro J. Safety of topical minoxidil solution: a one-year prospective observational study. Journal of Cutaneous Medicine and Surgery, 2003.
3. British Association of Dermatologists. Female Pattern Hair Loss, updated 2024.
4. UK prescribing information: Regaine for Women 5% Foam.
5. UK prescribing information: Minoxidil 5 mg Tablets.
6. US National Library of Medicine. LactMed: Minoxidil, updated May 2026.